Germany: Determining litigation value in patent appeals

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Germany: Determining litigation value in patent appeals

At last, Germany has clear guidelines regarding the litigation value of an appeal to the German Federal High Court of Justice (BGH) in patent application or opposition matters.

In its recent decision X ZB 3/15-Ratschenschlüssel II, the BGH provides patent applicants, patentees and opponents with clear guidelines on lower limits for the litigation value of an appeal to the BGH. Such appeals are possible under the German Patent Act subsequent to first instance appeal proceedings before the Federal Patent Court regarding a patent application or an opposition.

The determination of the litigation value of appeal proceedings before the Federal Court of Justice has to follow the same rules applicable to appeal proceedings before the Federal Patent Court. The litigation value shall therefore be determined with fair discretion, taking into account the parties' interest, but is limited by the value of the underlying judicial procedure.

In the case of an opposition to a patent, the objective interest of the parties may be quantifiable based on the value of the patent plus any claims for damages for which, in the absence of any other indication, the litigation value of pending or past infringement proceedings may provide the most tangible indication. The value of a patent that goes beyond this can be calculated with a surcharge of one quarter of the value of the infringement proceedings.

If there is no sufficient factual evidence for such an estimation, as in proceedings regarding a patent application, or in opposition proceedings without infringement of the patent, the value has to be determined differently. The fact that an applicant invests effort and expenses in the filing of a patent application and appealing against its refusal, and that the applicant will usually do so only in expectation of an associated economic benefit, justifies a minimum litigation value of €50,000 ($57,000). If a patent is opposed, a higher value is justified, namely €75,000 in case of a single opponent. If several parties oppose, this usually reflects an even greater general interest in the revocation of the patent, which justifies a further increase by €25,000 for each additional opponent.

Headnote BGH X ZB 3/15 (translated): The litigation value of the subject matter of a patent lawsuit shall be determined based on the reasonable interest of the appellant in accordance with the principles governing the valuation in nullity proceedings, if there is sufficient factual evidence for an estimate of the patent's intrinsic value. Otherwise, the litigation value in application proceedings is regularly €50,000. In opposition proceedings, the higher general interest is usually to be taken into account by means of a surcharge of €25,000 per opponent.

parchmann.jpg

Stefanie Parchmann


Maiwald Patentanwalts GmbHElisenhof, Elisenstr 3D-80335, Munich, GermanyTel: +49 89 74 72 660 Fax: +49 89 77 64 24info@maiwald.euwww.maiwald.eu

more from across site and SHARED ros bottom lb

More from across our site

François Pochart, Grégoire Desrousseaux and Lionel Martin, long-standing figures in the firm’s patent litigation team, are set to help launch a Paris-based litigation offering
The Unitary Patent has passed 100,000 registrations, but new data raises the question of whether 30% uptake is a ceiling or a staging post for further growth, say Michael Nielsen and Darren Smyth of EIP and Andrew Samm at Patently
The new generation of in-house IP leaders want commercial judgment, accessibility and flexibility, with AI raising expectations around both fees and delivery
The firm launched a San Diego office earlier this month, but California investment and expansion is far from complete
The industry’s response to AI requires an unfamiliar ingredient as firms battle to shape their futures
The firm is looking beyond replacing recently departed talent, betting instead on senior leaders to strengthen and expand its patent litigation platform
Olga Partington, director in Sterne Kessler’s biotechnology and chemical practice group, shares why a patent's vulnerability peaks when it is young, rather than when it is most valuable, under the PTAB's new framework
IP experts gathered in San Francisco last week to discuss the changing global SEP landscape and new licensing models for AI infrastructure
SKW Schwarz partner Daniel Kendziur explains how new green claims rules are changing his workload and bringing him into direct contact with marketing, PR and government affairs teams
The government is targeting earlier resolution of SEP disputes while ruling out a standalone IPEC rate determination track and restrictions on injunctions
Gift this article